Bayer Looks For New Partner As It Strives To Be A Player In Oncology Market

Nearly a decade after entering the oncology field, Bayer has three products on the market, two candidates in Phase II trials and a dozen more in Phase I trials; at ASCO it will talk to a potential partner about a combination drug study.